# Identification and Functional Implications of the E5 Oncogene Polymorphisms of Human Papillomavirus Type 16

**Authors:** Antônio Humberto P. da Silva-Júnior, Ruany Cristyne de Oliveira Silva, Ana Pavla A. Diniz Gurgel, Marconi Rêgo Barros-Júnior, Kamylla Conceição Gomes Nascimento, Daffany Luana Santos, Lindomar J. Pena, Rita de Cássia Pereira Lima, Marcus Vinicius de Aragão Batista, Bárbara Simas Chagas, Antonio Carlos de Freitas

PMC · DOI: 10.3390/tropicalmed9070140 · Tropical Medicine and Infectious Disease · 2024-06-26

## TL;DR

This study explores genetic variations in the E5 oncoprotein of HPV16 and their impact on cervical cancer development, focusing on how these variants affect the NF-κB pathway.

## Contribution

The study identifies specific E5 oncogene polymorphisms and their functional implications in modulating the NF-κB signaling pathway.

## Key findings

- HPV16 E5 variants were grouped into lineages A and D through phylogenetic analysis.
- Mutations in E5 were found in T-cell epitope regions, potentially affecting immune recognition.
- Variants HPV16E5_49PE and HPV16E5_85PE showed no increased pathway activation potential in the NF-κB pathway.

## Abstract

The persistence of the human papillomavirus type 16 (HPV16) infection on the cervical epithelium contributes to the progression of cervical cancer. Studies have demonstrated that HPV16 genetic variants may be associated with different risks of developing cervical cancer. However, the E5 oncoprotein of HPV16, which is related to several cellular mechanisms in the initial phases of the infection and thus contributes to carcinogenesis, is still little studied. Here we investigate the HPV16 E5 oncogene variants to assess the effects of different mutations on the biological function of the E5 protein. We detected and analyzed the HPV16 E5 oncogene polymorphisms and their phylogenetic relationships. After that, we proposed a tertiary structure analysis of the protein variants, preferential codon usage, and functional activity of the HPV16 E5 protein. Intra-type variants were grouped in the lineages A and D using in silico analysis. The mutations in E5 were located in the T-cell epitopes region. We therefore analyzed the interference of the HPV16 E5 protein in the NF-kB pathway. Our results showed that the variants HPV16E5_49PE and HPV16E5_85PE did not increase the potential of the pathway activation capacity. This study provides additional knowledge about the mechanisms of dispersion of the HPV16 E5 variants, providing evidence that these variants may be relevant to the modulation of the NF-κB signaling pathway.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** cervical cancer (MESH:D002583), carcinogenesis (MESH:D063646), infection (MESH:D007239)
- **Species:** Human papillomavirus 16 (serotype) [taxon 333760]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11281449/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11281449/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC11281449/full.md

---
Source: https://tomesphere.com/paper/PMC11281449